PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 21, 2026Cureus0 citationsOpen Access

Ketamine Use for ED Sedation: Pharmacologic Basis, Clinical Applications, and Safety Considerations

SMSabrina Gabriela Hernández MontoyaMartin UniversityCCChristian Andrés Soto CorderoMartin UniversityEZElia L ZamoraMartin University

Key Points

  • To evaluate the pharmacologic basis, clinical applications, and safety of ketamine in emergency department sedation.
  • Review of ketamine's receptor interactions and pharmacokinetics.
  • Analysis of clinical applications in sedation and pain management.
  • Comparison of adverse effects and hemodynamic stability with other agents.
  • Ketamine effectively provides sedation and analgesia while maintaining airway reflexes.
  • It demonstrates better hemodynamic stability than etomidate and a more favorable respiratory profile than benzodiazepine-opioid combinations.
  • Adverse reactions are rare but can include agitation or hallucinations, which can be alleviated by coadministering benzodiazepines.

Abstract

Ketamine is a versatile pharmacologic agent whose unique receptor interactions explain its broad applicability in emergency medicine. Its primary mechanism of action is non-competitive antagonism of N-methyl-D-aspartate (NMDA) receptors, which underlies its dissociative, anesthetic, and analgesic properties. By reducing excitatory neurotransmission and limiting glutamatergic activity, ketamine provides effective sedation while helping prevent neurotoxicity. Additional interactions with opioid, monoaminergic, and cholinergic systems contribute to its analgesic and psychotropic effects, reinforcing its neuroprotective and antidepressant potential. Ketamine is rapidly absorbed, crosses the blood-brain barrier efficiently, and is metabolized in the liver by cytochrome P450 enzymes CYP3A4 and CYP2B6 into active metabolites such as hydroxynorketamine. Its short half-life and multiple routes of administration, including IV, intramuscular (IM), and intranasal, allow for flexible use in different clinical contexts. In the ED, ketamine is used for procedural sedation, fracture and dislocation reduction, wound repair, and trauma management. Its dissociative properties ensure adequate analgesia and amnesia while preserving airway reflexes, reducing the need for additional anesthetic agents. It is particularly valuable in pediatric patients, providing effective sedation and pain control with minimal adverse effects. In cases of trauma, burns, or shock, the sympathomimetic activity of ketamine helps maintain cardiovascular tone and perfusion, offering an advantage over opioids, which may cause hypotension or respiratory depression. Adverse reactions are uncommon but may include laryngospasm, hypertension, tachycardia, or psychological emergence phenomena such as agitation or hallucinations. Coadministration of benzodiazepines can mitigate these effects and improve patient comfort during recovery. Standardized dosing protocols, typically 0.15-0.30 mg/kg IV for analgesia and 2-5 mg/kg IM for sedation, ensure both efficacy and safety. Comparative studies indicate that ketamine maintains hemodynamic stability better than etomidate and has a more favorable respiratory profile compared with benzodiazepine-opioid combinations. Overall, ketamine remains a cornerstone agent for emergency procedural sedation due to its rapid onset, reliability, and adaptability across a wide range of patient populations.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Montoya et al. (2026) studied this question.

synapsesocial.com/papers/69994ad4873532290d01f1fahttps://doi.org/10.7759/cureus.103774
Ask AI
Helpful
Bookmark
Share
View Full Paper